跳至主要内容
临床试验/NCT05982262
NCT05982262招募中不适用

Naturopathic-pharmacological Consultation on the Use of Dietary Supplements in Patients With Hematological Diseases

Bnai Zion Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年6月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Safety of the use of DHS in patients with a hematological disease through naturopathic counseling

研究概览

简要总结

The goal of this cross-sectional study is to learn about the effect of a naturopathic-pharmacologic consultation in patients with hematologic conditions. The main question it aims to answer is whether such consultation can improve the safety of dietary and herbal supplements' use among these patients.

Participants will be asked to answer basic questions and fill-out questionnaire before and after meeting the consultation team. Some patients will be prescribed dietary and herbal supplements that may help relief some of the symptoms they describe, in a safe way and without interacting with the drugs they are taking.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Followed up for a hematological condition
  • Ability to fill simple questionnaires in Hebrew, Russian or Arabic
  • Indication for consultation:
  • Patient's request to expand knowledge about the use of DHS
  • Patient using DHS
  • Patient's desire to start using DHS
  • Patient that is interested in hearing about the use of DHS for his/her health condition
  • Medical or nursing team's recommendation to take DHS for medical treatment or to improve compliance with conventional treatment.

排除标准

  • 未提供

研究组 & 干预措施

Patients with hematological conditions

Experimental

Patients will be referred by the medical or nursing staff of the Hematology Unit at the Bnai Zion Medical Center according to inclusion criteria

干预措施: Naturopathic-pharmacological consultation (Other)

结局指标

主要结局

Safety of the use of DHS in patients with a hematological disease through naturopathic counseling

时间窗: From enrollment to the end of intervention, up to 1 year

Number of potential interactions with moderate to major level of significance prevented by the naturopathic consultation in each patient, as well as the incidence of DHS-related safety events. The Naranjo and modified Food and Drug Administration algorithm will be used to assess the causality of such events with the specific dietary supplements, and only side effects at least possibly caused by the DHS according to these scales will be considered.

次要结局

  • Efficacy of prescribed dietary and herbal supplements (DHS)(From enrollment to the end of intervention, up to 1 year)
  • Patient-physician communication around the use of DHS(From enrollment to the end of intervention, up to 1 year)
  • Patient satisfaction(From enrollment to the end of intervention, up to 1 year)
  • Compliance with hematological treatment(From enrollment to the end of intervention, up to 1 year)
  • Qualitative evaluation of the staff and patients from naturopathic-pharmacological counseling(From enrollment to the end of intervention, up to 1 year)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验